Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.
2.

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE.

J Clin Endocrinol Metab. 2003 May;88(5):2318-26.

PMID:
12727991
3.

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.

J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. Epub 2005 Oct 11.

PMID:
16219715
4.

Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.

Park KY, Koh JM, Kim YI, Park HJ, Gong G, Hong SJ, Ahn IM.

Clin Endocrinol (Oxf). 1998 Sep;49(3):317-23.

PMID:
9861322
5.

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V.

J Clin Endocrinol Metab. 2002 Aug;87(8):3947-52.

PMID:
12161538
6.

The expression of PAX8-PPARgamma rearrangements is not specific to follicular thyroid carcinoma.

Nakabashi CC, Guimarães GS, Michaluart P Jr, Ward LS, Cerutti JM, Maciel RM.

Clin Endocrinol (Oxf). 2004 Aug;61(2):280-2. No abstract available.

PMID:
15272927
7.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

8.

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE.

Am J Surg Pathol. 2002 Aug;26(8):1016-23.

PMID:
12170088
9.

Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.

Frau DV, Lai ML, Caria P, Dettori T, Coni P, Faa G, Morandi L, Tallini G, Vanni R.

J Clin Endocrinol Metab. 2008 Jan;93(1):177-81. Epub 2007 Oct 23.

PMID:
17956956
10.

Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.

Banito A, Pinto AE, Espadinha C, Marques AR, Leite V.

Clin Endocrinol (Oxf). 2007 Nov;67(5):706-11. Epub 2007 Jul 25.

PMID:
17651453
11.

Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.

Caria P, Dettori T, Frau DV, Di Oto E, Morandi L, Parmeggiani A, Tallini G, Vanni R.

Am J Surg Pathol. 2012 Sep;36(9):1415-20. doi: 10.1097/PAS.0b013e318264bdd6.

PMID:
22895275
12.

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.

Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA.

Mod Pathol. 2010 Sep;23(9):1191-200. doi: 10.1038/modpathol.2010.112. Epub 2010 Jun 4.

13.

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG.

J Clin Endocrinol Metab. 2003 Jan;88(1):354-7.

PMID:
12519876
14.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

15.

Molecular pathology of well-differentiated thyroid carcinomas.

Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P.

Virchows Arch. 2005 Nov;447(5):787-93. Epub 2005 Sep 28. Review.

PMID:
16189702
16.

Molecular features of follicular variant papillary carcinoma of thyroid: comparison of areas with or without classical nuclear features.

Guney G, Tezel GG, Kosemehmetoglu K, Yilmaz E, Balci S, Ersoy R, Cakir B, Guler G.

Endocr Pathol. 2014 Sep;25(3):241-7. doi: 10.1007/s12022-013-9275-6.

PMID:
24277231
17.

[Oncogenes and thyroid tumors].

Lacroix L, Soria JC, Bidart JM, Schlumberger M.

Bull Cancer. 2005 Jan;92(1):37-43. Review. French.

18.

Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.

Di Cristofaro J, Marcy M, Vasko V, Sebag F, Fakhry N, Wynford-Thomas D, De Micco C.

Hum Pathol. 2006 Jul;37(7):824-30. Epub 2006 May 19.

PMID:
16784981
19.

Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.

Boaventura P, Pereira D, Celestino R, Mendes A, Nakasawa T, Teixeira-Gomes J, Sobrinho-Simões M, Soares P.

Eur J Endocrinol. 2013 Oct 3;169(5):673-9. doi: 10.1530/EJE-13-0543. Print 2013 Nov.

20.

Supplemental Content

Support Center